Home > News > Triton's nanotechnology designed to take on tumors
May 1st, 2004
Triton's nanotechnology designed to take on tumors
Samuel Straface is betting that nanotechnology originally designed to repair military vehicles can be successfully used for something far different: to kill cancer tumors. Straface is president and CEO of Triton BioSystems Inc. in Chelmsford, a 3-year-old biotechnology/medical device company hybrid. And he believes the company's system will essentially fry a tumor without significant side effects, ultimately helping to treat patients in lieu of toxic chemotherapy or radiation.
Graphene rubber bands could stretch limits of current healthcare, new research finds August 19th, 2014
Interaction between Drug, DNA for Designing Anticancer Drugs Studied in Iran August 17th, 2014
Scientists fold RNA origami from a single strand: RNA origami is a new method for organizing molecules on the nanoscale. Using just a single strand of RNA, this technique can produce many complicated shapes. August 14th, 2014
Iranian Scientists Stabilize Protein on Highly Stable Electrode Surface August 14th, 2014